Annual CFO
-$41.82 M
+$47.20 M+53.02%
31 December 2023
Summary:
Molecular Templates annual cash flow from operations is currently -$41.82 million, with the most recent change of +$47.20 million (+53.02%) on 31 December 2023. During the last 3 years, it has risen by +$41.98 million (+50.09%). MTEM annual CFO is now -239.81% below its all-time high of $29.91 million, reached on 31 December 2012.MTEM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$5.86 M
-$615.00 K-11.73%
30 June 2024
Summary:
Molecular Templates quarterly cash flow from operations is currently -$5.86 million, with the most recent change of -$615.00 thousand (-11.73%) on 30 June 2024. Over the past year, it has increased by +$1.68 million (+22.23%). MTEM quarterly CFO is now -113.88% below its all-time high of $42.21 million, reached on 31 March 2021.MTEM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$23.92 M
+$3.78 M+13.64%
30 June 2024
Summary:
Molecular Templates TTM cash flow from operations is currently -$23.92 million, with the most recent change of +$3.78 million (+13.64%) on 30 June 2024. Over the past year, it has increased by +$31.04 million (+56.47%). MTEM TTM CFO is now -146.83% below its all-time high of $51.09 million, reached on 31 March 2013.MTEM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MTEM Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +53.0% | +22.2% | +56.5% |
| 3 y3 years | +50.1% | +76.4% | +18.7% |
| 5 y5 years | -836.6% | +64.3% | -20.4% |
MTEM Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -37.6% | +53.0% | -11.7% | +78.8% | at high | +76.2% |
| 5 y | 5 years | -836.6% | +53.0% | -113.9% | +78.8% | -20.4% | +76.2% |
| alltime | all time | -239.8% | +53.0% | -113.9% | +78.8% | -146.8% | +76.2% |
Molecular Templates Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$5.86 M(+11.7%) | -$23.92 M(-13.6%) |
| Mar 2024 | - | -$5.24 M(-0.8%) | -$27.70 M(-33.8%) |
| Dec 2023 | -$41.82 M(-53.0%) | -$5.29 M(-29.8%) | -$41.82 M(-23.9%) |
| Sept 2023 | - | -$7.53 M(-21.8%) | -$54.97 M(-23.5%) |
| June 2023 | - | -$9.64 M(-50.2%) | -$71.86 M(-10.9%) |
| Mar 2023 | - | -$19.36 M(+5.0%) | -$80.69 M(-9.4%) |
| Dec 2022 | -$89.02 M(+193.0%) | -$18.43 M(-24.5%) | -$89.02 M(-4.3%) |
| Sept 2022 | - | -$24.43 M(+32.3%) | -$93.05 M(-0.4%) |
| June 2022 | - | -$18.47 M(-33.3%) | -$93.44 M(-6.8%) |
| Mar 2022 | - | -$27.70 M(+23.3%) | -$100.30 M(+230.1%) |
| Dec 2021 | -$30.39 M(-63.7%) | -$22.46 M(-9.5%) | -$30.39 M(+3.2%) |
| Sept 2021 | - | -$24.81 M(-2.1%) | -$29.43 M(+20.4%) |
| June 2021 | - | -$25.33 M(-160.0%) | -$24.44 M(+4.3%) |
| Mar 2021 | - | $42.21 M(-296.3%) | -$23.43 M(-72.0%) |
| Dec 2020 | -$83.80 M(+231.9%) | -$21.51 M(+8.5%) | -$83.80 M(+73.6%) |
| Sept 2020 | - | -$19.82 M(-18.5%) | -$48.26 M(+7.6%) |
| June 2020 | - | -$24.32 M(+34.0%) | -$44.84 M(+38.3%) |
| Mar 2020 | - | -$18.15 M(-229.4%) | -$32.42 M(+28.4%) |
| Dec 2019 | -$25.24 M(+465.4%) | $14.03 M(-185.6%) | -$25.24 M(+27.0%) |
| Sept 2019 | - | -$16.39 M(+37.7%) | -$19.88 M(+50.5%) |
| June 2019 | - | -$11.90 M(+8.4%) | -$13.21 M(+104.5%) |
| Mar 2019 | - | -$10.98 M(-156.6%) | -$6.46 M(+44.6%) |
| Dec 2018 | -$4.46 M(-68.7%) | $19.39 M(-299.5%) | -$4.46 M(-85.9%) |
| Sept 2018 | - | -$9.72 M(+88.7%) | -$31.77 M(+24.6%) |
| June 2018 | - | -$5.15 M(-42.6%) | -$25.50 M(+32.9%) |
| Mar 2018 | - | -$8.98 M(+13.6%) | -$19.18 M(+34.5%) |
| Dec 2017 | -$14.26 M(-43.2%) | -$7.91 M(+128.8%) | -$14.26 M(+30.0%) |
| Sept 2017 | - | -$3.46 M(-396.7%) | -$10.97 M(-15.6%) |
| June 2017 | - | $1.17 M(-128.7%) | -$13.00 M(-29.9%) |
| Mar 2017 | - | -$4.06 M(-12.1%) | -$18.53 M(-26.2%) |
| Dec 2016 | -$25.10 M(-34.0%) | -$4.62 M(-15.7%) | -$25.10 M(-10.5%) |
| Sept 2016 | - | -$5.48 M(+25.3%) | -$28.05 M(-15.7%) |
| June 2016 | - | -$4.37 M(-58.9%) | -$33.30 M(-25.7%) |
| Mar 2016 | - | -$10.63 M(+40.3%) | -$44.79 M(+17.9%) |
| Dec 2015 | -$38.00 M(+37.0%) | -$7.58 M(-29.3%) | -$38.00 M(-6.3%) |
| Sept 2015 | - | -$10.72 M(-32.4%) | -$40.55 M(-1.1%) |
| June 2015 | - | -$15.87 M(+313.0%) | -$40.99 M(+14.1%) |
| Mar 2015 | - | -$3.84 M(-62.1%) | -$35.94 M(+29.6%) |
| Dec 2014 | -$27.73 M | -$10.13 M(-9.2%) | -$27.73 M(+1.9%) |
| Sept 2014 | - | -$11.16 M(+3.2%) | -$27.22 M(+15.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | -$10.81 M(-348.0%) | -$23.48 M(+23.8%) |
| Mar 2014 | - | $4.36 M(-145.4%) | -$18.97 M(-286.9%) |
| Dec 2013 | $10.15 M(-66.1%) | -$9.61 M(+29.5%) | $10.15 M(-59.0%) |
| Sept 2013 | - | -$7.42 M(+17.8%) | $24.75 M(-17.3%) |
| June 2013 | - | -$6.30 M(-118.8%) | $29.92 M(-41.4%) |
| Mar 2013 | - | $33.48 M(+571.3%) | $51.09 M(+70.8%) |
| Dec 2012 | $29.91 M(-225.4%) | $4.99 M(-321.7%) | $29.91 M(+48.2%) |
| Sept 2012 | - | -$2.25 M(-115.1%) | $20.18 M(+25.4%) |
| June 2012 | - | $14.87 M(+20.8%) | $16.09 M(-390.6%) |
| Mar 2012 | - | $12.31 M(-359.6%) | -$5.54 M(-76.8%) |
| Dec 2011 | -$23.85 M(+6.6%) | -$4.74 M(-25.2%) | -$23.85 M(-1.8%) |
| Sept 2011 | - | -$6.34 M(-6.2%) | -$24.29 M(+1.1%) |
| June 2011 | - | -$6.76 M(+12.6%) | -$24.02 M(+4.5%) |
| Mar 2011 | - | -$6.00 M(+16.0%) | -$23.00 M(+2.7%) |
| Dec 2010 | -$22.38 M(+25.9%) | -$5.18 M(-14.8%) | -$22.38 M(+4.2%) |
| Sept 2010 | - | -$6.08 M(+5.9%) | -$21.48 M(+9.1%) |
| June 2010 | - | -$5.74 M(+6.5%) | -$19.69 M(+7.5%) |
| Mar 2010 | - | -$5.39 M(+26.1%) | -$18.31 M(+3.0%) |
| Dec 2009 | -$17.79 M(+9.1%) | -$4.27 M(-0.3%) | -$17.79 M(+1.4%) |
| Sept 2009 | - | -$4.29 M(-1.8%) | -$17.55 M(+3.2%) |
| June 2009 | - | -$4.36 M(-10.3%) | -$17.01 M(+2.5%) |
| Mar 2009 | - | -$4.87 M(+20.5%) | -$16.60 M(+1.8%) |
| Dec 2008 | -$16.31 M(-44.2%) | -$4.04 M(+7.7%) | -$16.31 M(-13.2%) |
| Sept 2008 | - | -$3.75 M(-5.2%) | -$18.79 M(-7.4%) |
| June 2008 | - | -$3.95 M(-13.6%) | -$20.30 M(-13.4%) |
| Mar 2008 | - | -$4.57 M(-29.8%) | -$23.45 M(-19.8%) |
| Dec 2007 | -$29.25 M(-37.0%) | -$6.52 M(+23.9%) | -$29.25 M(-11.5%) |
| Sept 2007 | - | -$5.26 M(-25.9%) | -$33.03 M(-17.7%) |
| June 2007 | - | -$7.10 M(-31.6%) | -$40.15 M(-11.8%) |
| Mar 2007 | - | -$10.37 M(+0.6%) | -$45.51 M(-2.0%) |
| Dec 2006 | -$46.42 M(+55.4%) | -$10.30 M(-16.7%) | -$46.42 M(+3.6%) |
| Sept 2006 | - | -$12.38 M(-0.7%) | -$44.83 M(+8.0%) |
| June 2006 | - | -$12.46 M(+10.4%) | -$41.52 M(+17.9%) |
| Mar 2006 | - | -$11.29 M(+29.6%) | -$35.23 M(+17.9%) |
| Dec 2005 | -$29.88 M(+176.7%) | -$8.71 M(-4.0%) | -$29.88 M(+41.1%) |
| Sept 2005 | - | -$9.07 M(+47.1%) | -$21.17 M(+75.0%) |
| June 2005 | - | -$6.17 M(+4.0%) | -$12.10 M(+104.0%) |
| Mar 2005 | - | -$5.93 M | -$5.93 M |
| Dec 2004 | -$10.80 M(+62.2%) | - | - |
| Dec 2003 | -$6.66 M(+169.7%) | - | - |
| Dec 2002 | -$2.47 M | - | - |
FAQ
- What is Molecular Templates annual cash flow from operations?
- What is the all time high annual CFO for Molecular Templates?
- What is Molecular Templates annual CFO year-on-year change?
- What is Molecular Templates quarterly cash flow from operations?
- What is the all time high quarterly CFO for Molecular Templates?
- What is Molecular Templates quarterly CFO year-on-year change?
- What is Molecular Templates TTM cash flow from operations?
- What is the all time high TTM CFO for Molecular Templates?
- What is Molecular Templates TTM CFO year-on-year change?
What is Molecular Templates annual cash flow from operations?
The current annual CFO of MTEM is -$41.82 M
What is the all time high annual CFO for Molecular Templates?
Molecular Templates all-time high annual cash flow from operations is $29.91 M
What is Molecular Templates annual CFO year-on-year change?
Over the past year, MTEM annual cash flow from operations has changed by +$47.20 M (+53.02%)
What is Molecular Templates quarterly cash flow from operations?
The current quarterly CFO of MTEM is -$5.86 M
What is the all time high quarterly CFO for Molecular Templates?
Molecular Templates all-time high quarterly cash flow from operations is $42.21 M
What is Molecular Templates quarterly CFO year-on-year change?
Over the past year, MTEM quarterly cash flow from operations has changed by +$1.68 M (+22.23%)
What is Molecular Templates TTM cash flow from operations?
The current TTM CFO of MTEM is -$23.92 M
What is the all time high TTM CFO for Molecular Templates?
Molecular Templates all-time high TTM cash flow from operations is $51.09 M
What is Molecular Templates TTM CFO year-on-year change?
Over the past year, MTEM TTM cash flow from operations has changed by +$31.04 M (+56.47%)